CDKN2A and neoplasm: Although the tumor suppressor genes K-ras, p53, CDKN2A and SMAD4 have found to be the central molecular genetic pathways in pancreatic cancer33, 34, 35, 36, the gained survival advantage targeting aforementioned pathways remain limited.